
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
β-tectorin CRISPR/Cas9 KO Plasmid (m) | sc-423332 | 20 µg | $397.00 |
Tectb encodes β-tectorin, a secreted glycoprotein that contributes to the extracellular matrix architecture of the inner ear tectorial membrane, where it helps organize supramolecular assemblies important for cochlear mechanics. By shaping the biomechanical coupling between the tectorial membrane and hair-cell stereocilia, β-tectorin supports efficient mechanoelectrical transduction and sound-evoked signaling. Disruption of tectorial membrane matrix components, including β-tectorin-associated networks, is linked to altered auditory thresholds and sensorineural hearing phenotypes, making Tectb a useful locus for studying matrix-dependent regulation of sensory function. In mouse models, Tectb perturbation enables analysis of extracellular matrix assembly, epithelial secretion, and structure–function relationships underlying auditory processing.
β-tectorin CRISPR/Cas9 KO Plasmid (m) is a pool of plasmids designed for targeted disruption of the Tectb gene in mouse cell lines. Each plasmid co-expresses a unique single guide RNA (sgRNA) targeting a distinct site within the Tectb together with the Streptococcus pyogenes Cas9 nuclease. The plasmids also encode GFP, allowing fluorescent identification and enrichment of successfully transfected cells by fluorescence microscopy or flow cytometry.
The multi-guide design increases the likelihood of generating insertions or deletions (indels) that disrupt the Tectb open reading frame following Cas9-mediated double-strand break formation. DNA breaks introduced by the CRISPR/Cas9 system are repaired through endogenous non-homologous end joining (NHEJ) pathways, frequently resulting in frameshift mutations that abolish β-tectorin protein expression.
This CRISPR knockout system enables efficient generation of Tectb-deficient cell models for investigation of β-tectorin signaling, functional genomics studies, cancer biology research, and evaluation of therapeutic responses in human cell lines.
CRISPRs +/- HDRs
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.